Pathstone Holdings
MEDP icon

Pathstone Holdings’s Medpace MEDP Stock Holding History

Pathstone Holdings’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.4M Buy
15,870
+9,255
+140% +$4.27M 0.02% 470
2026
Q1 		$3.18M Buy
6,615
+181
+3% +$92.7K 0.01% 785
2025
Q4 		$3.61M Sell
6,434
-1,889
-23% -$1.07M 0.01% 707
2025
Q3 		$4.28M Sell
8,323
-228
-3% -$99.5K 0.02% 618
2025
Q2 		$2.68M Sell
8,551
-2,812
-25% -$844K 0.01% 832
2025
Q1 		$3.46M Hold
11,363
– – 0.02% 701
2024
Q4 		$3.78M Buy
11,363
+845
+8% +$287K 0.02% 653
2024
Q3 		$3.51M Sell
10,518
-1,193
-10% -$453K 0.02% 692
2024
Q2 		$4.82M Buy
11,711
+853
+8% +$338K 0.02% 540
2024
Q1 		$4.39M Buy
10,858
+5,802
+115% +$2.04M 0.02% 548
2023
Q4 		$1.55M Buy
+5,056
New +$1.36M 0.01% 834

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Pathstone Holdings's MEDP Position: Q2 2026 in Review

Pathstone Holdings increased its Medpace (MEDP) stake by 140% in Q2 2026, buying an estimated $4.27M and bringing the position to 15,870 shares worth $8.4M. The position accounts for 0.02% of the portfolio, ranked #470.

Pathstone Holdings first reported a position in MEDP in Q4 2023 and has held it in 11 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Pathstone Holdings held 15,870 shares of Medpace worth $8.4M as of Q2 2026.
  • Pathstone Holdings bought 9,255 Medpace shares in Q2 2026, an estimated $4.27M.
  • Medpace made up 0.02% of Pathstone Holdings's portfolio in Q2 2026, its #470 holding.
  • Pathstone Holdings first reported a position in Medpace in Q4 2023 and has held it in 11 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.